Skip to main content
Fig. 3 | BMC Medical Imaging

Fig. 3

From: A gadoxetic acid-enhanced MRI-based model using LI-RADS v2018 features for preoperatively predicting Ki-67 expression in hepatocellular carcinoma

Fig. 3

Hepatocellular carcinoma in the right lobe of liver showed heterogenous hypointense with blood products on T1-weighted imaging (A, B), heterogenous hyperintense on T2-weighted imaging (C), hyperintense on DWI (D) while hypointense on apparent diffusion coefficient map (E), hypointense on precontrast T1-weighted imaging (F), arterial phase hyperenhancement (APHE) on arterial phase (G), washout, mosaic architecture and infiltrative appearance on portal venous phase (H) and transitional phase (I), and apparent hypointense without targetoid appearence on hepatobiliary phase (J). H Pathology revealing hepatocellular carcinoma (HE × 10). I Immunohistochemistry showing high proliferative activity of tumor cells with approximately 50% Ki-67 expression (× 10)

Back to article page

BMC Medical Imaging

ISSN: 1471-2342

Contact us